• Home
  • News
  • Apple and Johnson & Johnson Collaborating on New Heart Health AFib Diagnosis Program

Apple and Johnson & Johnson Collaborating on New Heart Health AFib Diagnosis Program

Apple and Johnson & Johnson Collaborating on New Heart Health AFib Diagnosis Program

Johnson & Johnson on Thursday announced it has entered a heart health research study with Apple. The program uses a Johnson & Johnson-developed app and the Apple Watch Series 4’s irregular heart rhythm and ECG app to accelerate the diagnosis of atrial fibrillation.

The study aims to analyze the impact of Apple Watch on the early detection and diagnosis of AFib, and the potential to improve outcomes including the prevention of stroke. A multi-year research program will be launched later in 2019. This large-scale program will occur in the U.S. only, and will be designed as a pragmatic randomized controlled research study for individuals age 65 years or older.

The study’s goals include:

  • Measuring the outcomes of a heart health engagement program with irregular rhythm notifications on Apple Watch.
  • Assessing the impact of a medication adherence program using an app from Johnson & Johnson.

“We’re excited about the potential of common, wearable technology to aid in the earlier detection and prevention of a frequent cause of stroke,” said Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. “Too many people living with AFib are unaware of their risk, and earlier detection, diagnosis and treatment of AFib could significantly improve outcomes. Based on the insights generated through this research program, we may be able to develop new ways to detect other health conditions earlier in the future that also exhibit measurable physiological symptoms.”

“Through Apple Watch people have been able to learn more about their heart health, including discovering they have AFib. This kind of information empowers customers to follow up with the right treatment or even better, implement healthy habits aimed at prevention,” said Jeff Williams, Chief Operating Officer, Apple Inc. “We’re excited to work with Johnson & Johnson, a leader in the medical community, as we learn about the impact Apple Watch can have in delivering better health outcomes.”

The multi-year research program will launch later this year.

  1. dumps cvv says:

    139104 324902Superb read, I just passed this onto a colleague who was performing just a little research on that. And he really bought me lunch as I found it for him smile So let me rephrase that: Thank you for lunch! 888127

  2. 975915 985740Heya just wanted to give you a brief heads up and let you know a couple of with the pictures arent loading properly. Im not certain why but I feel its a linking issue. Ive tried it in two different web browsers and both show exactly the same outcomes. 301034

Leave a Reply

Your email address will not be published. Required fields are marked *